Expression of the p53 target CDIP correlates with sensitivity to TNFα-induced apoptosis in cancer cells

Cancer Research

Volumn 72, Issue 9, 2012, Pages 2373-2382

  Brown Endres, Lauren ^a   Schoenfeld, David ^a   Tian, Fang ^a   Kim, Hyung Gu ^a   Namba, Takushi ^a   Muñoz Fontela, César ^c   Mandinova, Anna ^a,b   Aaronson, Stuart A ^c   Lee, Sam W ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN CDIP; PROTEIN P53; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CELL DEATH; CELL FATE; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84860523524     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3369     Document Type: Article

References (24)

1. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001;11:372-7. (Pubitemid 32900529)
2. Grivennikov SI, Karin M. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis 2011;70 Suppl 1:i104-8.
3. Peter ME, Krammer PH. The CD95 (APO-1/Fas) DISC and beyond. Cell Death Differ 2003;10:26-35.
4. Wajant H,Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003;10:45-65. (Pubitemid 36511832)
5. Thorburn A. Death receptor-induced cell killing. Cell Signal 2004;16: 39-44.
6. Micheau O, Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003;114:181-90. (Pubitemid 36936912)
7. Muppidi JR, Tschopp J, Siegel RM. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 2004;21:461-5. (Pubitemid 39370502)
8. WuH, Lozano G. NF-kappaBactivation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 1994;269:20067-74.
9. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-kappaB in p53-mediated programmed cell death. Nature 2000;404:892-7. (Pubitemid 30230343)
10. Oren M, Cooks T. NFkB and p53: A life and death affair. Cell Cycle 2010;9:1027.
11. Schneider G, Henrich A, Greiner G, Wolf V, Lovas A, Wieczorek M, et al. Cross talk between stimulated NF-kappaB and the tumor suppressor p53. Oncogene 2010;29:2795-806.
12. Ak P, Levine AJ. p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism. FASEB J 2010;24:3643-52.
13. Brown L, Ongusaha PP, Kim HG, Nuti S, Mandinova A, Lee JW, et al. CDIP, a novel proapoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner. EMBO J 2007;26:3410-22. (Pubitemid 47123544)
14. Deng Y. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 2003;115:61-70. (Pubitemid 37255318)
15. Papa S, Bubici C, Zazzeroni F, Pham CG, Kuntzen C, Knabb JR, et al. The NF- kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease. Cell Death Differ 2006;13:712-29.
16. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 2001;98:13681-6. (Pubitemid 33115958)
17. Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K. JNK phosphorylates paxillin and regulates cell migration. Nature 2003;424:219-23. (Pubitemid 36858692)
18. Kawauchi T, Chihama K, Nabeshima Y, Hoshino M. The in vivo roles of STEF/Tiam1, Rac1 and JNK in cortical neuronal migration. EMBO J 2003;22:4190-201. (Pubitemid 37021747)
19. Liu ZG, Hsu H, Goeddel DV, Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NFkappaB activation prevents cell death. Cell 1996;87:565-76. (Pubitemid 26374329)
20. Xu Y, Kiningham KK, Devalaraja MN, Yeh CC, Majima H, Kasarskis EJ, et al. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 1999;18: 709-22. (Pubitemid 29439223)
21. Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D, Ogi J, et al. Manganese superoxide dismutatase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 2003;23:2362-78. (Pubitemid 36351019)
22. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005;120: 649-61. (Pubitemid 40343077)
23. Kunsch C, Rosen CA. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 1993;13:6137-46. (Pubitemid 23292608)
24. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-3.